[{"fields": {"keywords": "acrdinium ester, AE probe, design, HPA, chemiluminescence", "document": "feasibility/AE_dmr_probe_DH_summary.pdf", "year": 1996, "author": "from Nelson, N.C., Hannond, P.W., Matsuda, E., Goud, A.A. & Becker, M.M.\r\n", "title": "on Optimal Sites for AE Labels in Probes"}, "model": "feasibility.FeasibilityDocuments", "pk": 1}, {"fields": {"keywords": "acridinium ester, chemiluminescence, linker site, dimer", "document": "feasibility/AE_LINKER_study_Hammond_04Mar1989.pdf", "year": 1989, "author": "Hammond, P.\r\n", "title": "AE-Linker Location Dimer site study"}, "model": "feasibility.FeasibilityDocuments", "pk": 2}, {"fields": {"keywords": "TMA, real-time, multiplex, molecular torch, fluorescence", "document": "feasibility/Best_Torch_Stem_Sequence_for_Multiplex_Kaminsky_06Aug2009.pdf", "year": 2009, "author": "Kaminsky, M.", "title": "Determine best torch stem sequence for optimal multiplex real-time TMA performance in the T2/ERGa, PSA and CAP2 system"}, "model": "feasibility.FeasibilityDocuments", "pk": 3}, {"fields": {"keywords": "molecular beacon, design, fluorescence", "document": "feasibility/Design_Soluble_MBs_General_Principles_Becker_et_al_Apr2002.pdf", "year": 2002, "author": "Becker, M.M. (Banerjee, A. R. & Majlessi, M.)", "title": "Design of Soluble Molecular Beacons: General Principles"}, "model": "feasibility.FeasibilityDocuments", "pk": 4}, {"fields": {"keywords": "oligonucleotide, design, primer, capture oligo, AE probe", "document": "feasibility/Oligonucleotide_Design_guidelines_Carlson_Jul2001.pdf", "year": 2001, "author": "Carlson, J.", "title": "Design of General guidelines and Experimental Recommendations for a new Amplification Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 5}, {"fields": {"keywords": "TMA, primer decoy, side products", "document": "feasibility/Primer_Decoys_summary_Adams_30Jul1997.pdf", "year": 1997, "author": "Adams, C.", "title": "Primer Decoys"}, "model": "feasibility.FeasibilityDocuments", "pk": 6}, {"fields": {"keywords": "TMA, real time, multiplex, molecular beacon, design, fluorescence, Neisseria gonorrhoeae (Ngo) ", "document": "feasibility/Specific_Detection_Ngo_using_MBs_Nelson_25Jul2001.pdf", "year": 2001, "author": "Nelson, N.C.", "title": "Specific Detection of Neisseria gonorrhoeae using Molecular Beacons"}, "model": "feasibility.FeasibilityDocuments", "pk": 7}, {"fields": {"keywords": "TMA, real time, molecular torch, multiplex, Rox, acridine, fluorescein, fluorescence", "document": "feasibility/Evaluation of Acridine_Fam_Interaction_summary_Kaminsky_Jan2009.pdf", "year": 2009, "author": "Kaminsky, M.", "title": "Evaluation of possible bleeding of Rox-Acridine torches to the Fam channel"}, "model": "feasibility.FeasibilityDocuments", "pk": 8}, {"fields": {"keywords": "TMA, real time, multiplex, molecular torch, fluorescence", "document": "feasibility/Fluorescent_Dye_Summary_Kaminsky_Aug2009.pdf", "year": 2009, "author": "Kaminsky, M.", "title": "Fluorescent Dye Summary"}, "model": "feasibility.FeasibilityDocuments", "pk": 9}, {"fields": {"keywords": "fluorescence, quenching, mechanisms", "document": "feasibility/Quenchers_Kaminsky_01Jun2007.pdf", "year": 2007, "author": "Kaminsky, M.", "title": "on Quenchers and Quenching Mechanisms"}, "model": "feasibility.FeasibilityDocuments", "pk": 10}, {"fields": {"keywords": "fluorescence, quenchers ", "document": "feasibility/Quenchers_Kaminsky_26Nov2007.pdf", "year": 2007, "author": "Kaminsky, M.", "title": "Quenchers"}, "model": "feasibility.FeasibilityDocuments", "pk": 11}, {"fields": {"keywords": "sample transport, cellularity control, Aldrithiol-4, thiol reactive dye, PCA polymer, PDA lipsome, boronate chemosensor ", "document": "feasibility/APTIMA_Transport_Cellularity_Control_evaluation_report_Getman_and_Howell_21Dec2009.pdf", "year": 2009, "author": "Getman, D. & Howell, C.", "title": "Technology evaluation for APTIMA transport cellularity control"}, "model": "feasibility.FeasibilityDocuments", "pk": 12}, {"fields": {"keywords": "target capture, TMA, reverse, real time, fluorescence, whole blood", "document": "feasibility/Methods_for_Whole_Blood_Specimen_Testing_by_TMA_feasibility_report_Jost_04Dec2009.pdf", "year": 2009, "author": "Jost, M.,* Nelson, L., Wang, R., Kacian, D. & Reynolds, M.", "title": "Methods development for whole blood specimens testing by TMA"}, "model": "feasibility.FeasibilityDocuments", "pk": 13}, {"fields": {"keywords": "lysis, bacteria, fungi, detergent, alkaline, hypotonic, heat", "document": "feasibility/Report_universal_lysis_Walcher_080207.pdf", "year": 2007, "author": "Walcher, M.", "title": "Summary universal lysis method"}, "model": "feasibility.FeasibilityDocuments", "pk": 14}, {"fields": {"keywords": "specimen stabilization, urine, PreservCyt\u00ae, Saccomanno, Methacarn, RCL-2, UMFIX, IDU/DU, Citric acid/phosphate buffer, alcohols, PEG, Mercuric oxide, boric acid, sodium acetate, ciprofloxacin ", "document": "feasibility/Urine_Stabilization_Method_technical_report_Jost_and_Day_06Oct2008.pdf", "year": 2008, "author": "Jost, M. & Day, J.", "title": "Urine Stabilization Method"}, "model": "feasibility.FeasibilityDocuments", "pk": 15}, {"fields": {"keywords": "target capture, target capture oligonucleotides, dT14, magnetic particles, ", "document": "feasibility/a_target_capture_in_action_video_clip.mov", "year": null, "author": "", "title": "Target Capture video"}, "model": "feasibility.FeasibilityDocuments", "pk": 16}, {"fields": {"keywords": "target capture, bacterial 16S universal, PCR, real time, fluorescence", "document": "feasibility/b_16S_Bacterial_TCR_summary_report_Yamagata_14Oct2009.pdf", "year": 2009, "author": "Yamagata, S.", "title": "16S Bacterial TCR"}, "model": "feasibility.FeasibilityDocuments", "pk": 17}, {"fields": {"keywords": "target capture, nonspecific, particles, Cortex", "document": "feasibility/Evaluation_of_MagaPureEX_Particles_from_Cortex_Biochem_Kaminsky_Nelson_20May2002.pdf", "year": 2002, "author": "Kaminsky, M. & Nelson, N.", "title": "Evaluation of MagaPureEX\u2122 Particles from Cortex Biochem"}, "model": "feasibility.FeasibilityDocuments", "pk": 18}, {"fields": {"keywords": "target capture, specific, L-ribose, HIV-1", "document": "feasibility/HIV-1_NextGen_Target_Capture_report_Yamagata_22Dec2009.pdf", "year": 2009, "author": "Yamagata, S.", "title": "HIV-1 Next Generation Target Capture"}, "model": "feasibility.FeasibilityDocuments", "pk": 19}, {"fields": {"keywords": "target capture, nonspecific, particles, chaotropes, salt, organic solvents, rRNA, gDNA, ", "document": "feasibility/Nonspecific_Nucleic_Acid_Sample_Processing_Results_obtained_in_2002_Browne_et_al_18Dec2002.pdf", "year": 2002, "author": "Browne, K.A., Kaminsky, M. & Nelson, N.", "title": "Nonspecific Nucleic Acid Sample Processing"}, "model": "feasibility.FeasibilityDocuments", "pk": 20}, {"fields": {"keywords": "target capture, nonspecific, TMA, real-time, fluorescence", "document": "feasibility/Rapid_Target_Capture_Report_Amersdorfer_et_al_28Dec2004.pdf", "year": 2004, "author": "Amersdorfer, P., Kaminsky, M., Subramanian, G., Clemmons, W. & Nelson, N.", "title": "Rapid Target Capture Integrated with Realtime TMA"}, "model": "feasibility.FeasibilityDocuments", "pk": 21}, {"fields": {"keywords": "target capture, specific, rRNA", "document": "feasibility/Single_and_Two_Step_Capture_of_Specific_Nucleic_Acids_feasibility_report_Majlessi_and_Becker_09Jun2003.pdf", "year": 2003, "author": "Majlessi, M. & Becker, M.", "title": "Feasibility Report: Single- and Two-Step Capture of a Specific Nucleic Acid"}, "model": "feasibility.FeasibilityDocuments", "pk": 22}, {"fields": {"keywords": "TMA, multiplex, target capture, TACO", "document": "feasibility/Target_Activated_Capture_Oligos_report__Aug2009.pdf", "year": 2009, "author": "Carlson, J.?", "title": "Specific Target Capture Report"}, "model": "feasibility.FeasibilityDocuments", "pk": 23}, {"fields": {"keywords": "target capture, ChargeSwitch, MinElute, NucliSENS, PCR, real time, fluorescence ", "document": "feasibility/Target_Capture_Pollner_26Aug2008.pdf", "year": 2008, "author": "Pollner, R.", "title": "Target Capture White Paper"}, "model": "feasibility.FeasibilityDocuments", "pk": 24}, {"fields": {"keywords": "Transcription-Mediated Amplification, primers, template, amplicon", "document": "feasibility/a_TMA_in_action_video_clip.mov", "year": null, "author": "", "title": "TMA video"}, "model": "feasibility.FeasibilityDocuments", "pk": 25}, {"fields": {"keywords": "RT-PCR, multiplex, end point, capillary electrophoresis, ", "document": "feasibility/Althea_Multiplex_Platform_feasibility_report_Kastury_and_James_15Oct2006.pdf", "year": 2006, "author": "Kastury, K. & James, A.", "title": "Evaluation Of Althea Multiplex Platform"}, "model": "feasibility.FeasibilityDocuments", "pk": 26}, {"fields": {"keywords": "TMA, real time, design, contamination control", "document": "feasibility/Amplification_101_class_Carlson_07May2009.pdf", "year": 2009, "author": "Carlson, J.", "title": "Amplification 101"}, "model": "feasibility.FeasibilityDocuments", "pk": 27}, {"fields": {"keywords": "TMA, enzyme purification, anion exchange, acridinium ester, chemiluminescence", "document": "feasibility/Anion_exchanged_purified_RT_T7RNAP_in_TMA_assay_Russell_et_al_Jun2002.pdf", "year": 2002, "author": "Russell, J., Filipowsky, M., Dai, L. & Woolley, J.", "title": "Use of RT & T7 enzymes, Purified by Strong Anion Exchange (SAX) Chromatography in the TMA Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 28}, {"fields": {"keywords": "TMA, universal, real time, multiplex, molecular beacon, fluorescence", "document": "feasibility/Balancing_analytes_interactions_by_using_Displacers_and_NT7_modification_Kaminsky_Oct2007.pdf", "year": 2007, "author": "Kaminsky, M.", "title": "RUf TMA. Multiplex. Balancing effect of analyte-to-analyte interaction by using Displacers; designing Modified Non-T7 primers"}, "model": "feasibility.FeasibilityDocuments", "pk": 29}, {"fields": {"keywords": "TMA, reverse, real time, hybrid primer, molecular torch, fluorescence, side product, ", "document": "feasibility/DNA_RNA_Primer_Hybrids_in_RTMA_Reactions_report_BubeckBarrett_Nov2009.pdf", "year": 2009, "author": "Bubeck-Barrett, A. (Quinones-Olson, P., Li, W., Jiang, A., Becker, M., Campbell, P. & Majlessi, M.)", "title": "Use of DNA/RNA primer hybrids in RTMA reactions"}, "model": "feasibility.FeasibilityDocuments", "pk": 30}, {"fields": {"keywords": "LAMP, isothermal amplification, real time, multiplex, Bst polymerase, molecular beacon, fluorescence ", "document": "feasibility/Eiken_LAMP_Amplification_Evaluation_Report_Brentano_et_al_Mar2002.pdf", "year": 2002, "author": "Brentano, S., Carlson, J. & Hanna, B.", "title": "Eiken LAMP Amplification"}, "model": "feasibility.FeasibilityDocuments", "pk": 31}, {"fields": {"keywords": "TMA, multiphase, real time, molecular torch, fluorescence", "document": "feasibility/HIV_Multiphase_TMA_report_Blazie_et_al_18Mar2010.pdf", "year": 2010, "author": "Blazie, S., Phelps, S. & Nelson, N.", "title": "HIV Forward TMA Multiphase Amplification"}, "model": "feasibility.FeasibilityDocuments", "pk": 32}, {"fields": {"keywords": "TMA, 3'-mismatch, acridinium ester, chemiluminescence", "document": "feasibility/HIV_pol_Primer_Mismatch_summary_Brentano_06Mar2000.pdf", "year": 2000, "author": "Brentano, S.", "title": "1997 HIV pol primer mismatch study"}, "model": "feasibility.FeasibilityDocuments", "pk": 33}, {"fields": {"keywords": "PCR, isothermal, Bst polymerase, betaine, acridinium ester, chemiluminescence", "document": "feasibility/Isothermal_PCR_summary_presentationLivezey_and_Becker_25Apr2002.pdf", "year": 2002, "author": "Livezey, K. & Becker, M.", "title": "Isothermal PCR (ICR)"}, "model": "feasibility.FeasibilityDocuments", "pk": 34}, {"fields": {"keywords": "linear amplification, multiplex, Zipex Array", "document": "feasibility/Linear_Amplification_using_DH_Primers_Nelson_et_al_24Apr2009.pdf", "year": 2009, "author": "Nelson, L., Jost, M. & Reynolds, M.", "title": "Linear Amplification using DH-Primers"}, "model": "feasibility.FeasibilityDocuments", "pk": 35}, {"fields": {"keywords": "TMA, reverse, real time, molecular switch, fluorescence, Tm analysis", "document": "feasibility/MolecularSwitches_project_report_Hussein_11Dec2009.pdf", "year": 2009, "author": "Hussein, R.", "title": "Molecular Switches"}, "model": "feasibility.FeasibilityDocuments", "pk": 36}, {"fields": {"keywords": "target capture, TMA, multiplex, reverse, universal, real time, molecular torch, fluorescence", "document": "feasibility/Mulitplex_TMA_Project_summary_report_Lyakhov_et_al_29Dec2007.pdf", "year": 2007, "author": "Lyakhov, D., Phelps, S., Chelliserrykattil, J., Siegrist, J., Carlson, J., Kaminsky, M., Gordon, P., Hashima, S., Ngo, T., Dai, L. (ad hoc), Vu, H. (ad hoc), Brentano, S. & Nelson, N.", "title": "Multiplex TMA Project"}, "model": "feasibility.FeasibilityDocuments", "pk": 37}, {"fields": {"keywords": "TMA, RNAP mutant, acridinium ester, chemiluminescence", "document": "feasibility/Mutagenesis_of_T7_RNA_Polymerase_report_Lyakhov_2001.pdf", "year": 2001, "author": "Lyakhov, D.", "title": "Mutagenesis of T7 RNA Polymerase"}, "model": "feasibility.FeasibilityDocuments", "pk": 38}, {"fields": {"keywords": "extended dynamic range, algorithm, acridinium ester, chemiluminescence", "document": "feasibility/Nonlinear_Regression_Extended_Dynamic_Range_Kennedy_30Apr2002.pdf", "year": 2002, "author": "Kennedy, M.", "title": "Mechanistic Model and Nonlinear Regression of Extended Dynamic Range Quant HCV Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 39}, {"fields": {"keywords": "TMA, multiplex, universal, real time, split, molecular torch, fluorescence", "document": "feasibility/Quadruplex_TMA_summary_report_Phelps_et_al_04Nov2008.pdf", "year": 2008, "author": "Phelps, S., Chelliserrykattil, J., Peng, D., Kaminsky, M. & Nelson, N.", "title": "Quadruplex TMA Project"}, "model": "feasibility.FeasibilityDocuments", "pk": 40}, {"fields": {"keywords": "TMA, real time, multiplex, molecular beacon, fluorescence", "document": "feasibility/Real_time_TMA_summary_report_Fu_Mar2001.pdf", "year": 2001, "author": "Fu, T.-J.", "title": "Real-time TMA"}, "model": "feasibility.FeasibilityDocuments", "pk": 41}, {"fields": {"keywords": "TMA, reverse, acridinium ester, chemiluminescence, real time, multiplex, molecular beacon, fluorescence", "document": "feasibility/RTMA_Feasibility_Livezey_et_al_Feb2004.pdf", "year": 2004, "author": "Livezey, K., Lam, W.C., Norton, K. & Becker, M.", "title": "Reverse TMA (RTMA)"}, "model": "feasibility.FeasibilityDocuments", "pk": 42}, {"fields": {"keywords": "TMA, mulitplex, real time, fluorescence", "document": "feasibility/SampleSplit_pre-amp_TMA_Shapiro_29Oct2009.pdf", "year": 2009, "author": "Shapiro, A.-L.", "title": "Sample Split Pre-Amp TMA"}, "model": "feasibility.FeasibilityDocuments", "pk": 43}, {"fields": {"keywords": "TMA, pre-amp/split, real time, fluorescence, AMACR, PSA, PCA3, T2ErgC", "document": "feasibility/spTMA_technology_report_Lyakhov_and_Brentano_2010.pdf", "year": 2010, "author": "Lyakhov, D. & Brentano, S.", "title": "Pre-Amp/Split TMA"}, "model": "feasibility.FeasibilityDocuments", "pk": 44}, {"fields": {"keywords": "TMA, acridinium ester, chemiluminescence, T3 instead of T7 RNAP", "document": "feasibility/T3_in_TMA_feasibility_report_Adams_Nov1995.pdf", "year": 1995, "author": "Adams, C.C.", "title": "T3 RNA polymerase performance evaluation"}, "model": "feasibility.FeasibilityDocuments", "pk": 45}, {"fields": {"keywords": "TMA, real time, T3 instead of T7 RNAP", "document": "feasibility/T3_RNA_Polymerase_summary_report_Yamagata_27May2009.pdf", "year": 2009, "author": "Yamagata, S.", "title": "T3 RNA POLYMERASE"}, "model": "feasibility.FeasibilityDocuments", "pk": 46}, {"fields": {"keywords": "TMA, multiplex, tag sequences", "document": "feasibility/Tag_Seq_Minimize_Multiplex_TMA_Interferences_Blazie_et_al_27Dec2009.pdf", "year": 2009, "author": "Blazie, S., Chelliserrykattil, J. & Nelson, N.", "title": "Screening Tag Sequences to Minimize Interferences in Multiplex TMA"}, "model": "feasibility.FeasibilityDocuments", "pk": 47}, {"fields": {"keywords": "TMA, switched reverse universal half, real time, molecular torch, fluorescence", "document": "feasibility/Tagged_Approach_to_RTMA_for_HIV_summary_report_Blazie_e_al_10Mar2009.pdf", "year": 2009, "author": "Blazie, S., Phelps, S. & Nelson, N.", "title": "Tagged Approach to RTMA for HIV"}, "model": "feasibility.FeasibilityDocuments", "pk": 48}, {"fields": {"keywords": "TMA, RNA, end-point, real time, quantitative", "document": "feasibility/TMA_Assays_and_Technologies_presentation_Brentano_17Apr2009.pdf", "year": 2009, "author": "Brentano, S.", "title": "TMA Assays and Technologies"}, "model": "feasibility.FeasibilityDocuments", "pk": 49}, {"fields": {"keywords": "TMA, promoter-primer, non-T7 primer, T7 RNAP, RT, amplicon", "document": "feasibility/TMA_mechanism.pdf", "year": null, "author": "", "title": "TMA mechanism"}, "model": "feasibility.FeasibilityDocuments", "pk": 50}, {"fields": {"keywords": "TMA, promoter-primer, non-T7 primer, T7 RNAP, RT, amplicon", "document": "feasibility/TMA_mechanism_animated_slides.PPT", "year": null, "author": "", "title": "TMA mechanism, animated"}, "model": "feasibility.FeasibilityDocuments", "pk": 51}, {"fields": {"keywords": "TMA, universal, acridinium ester, chemiluminescence", "document": "feasibility/Universal_TMA_Feasibility_Report_Carlson_Lyakhov_2004.pdf", "year": 2004, "author": "Carlson, J. & Lyakhov, D.", "title": "Type 1 (Plus S-oligo Assembly) and Type 2 (No S-oligo Assembly) Universal Transcription Mediated Amplification (UTMA)"}, "model": "feasibility.FeasibilityDocuments", "pk": 52}, {"fields": {"keywords": "TMA, universal, uTMA, S-oligo", "document": "feasibility/uTMA_rationale__07May2004.pdf", "year": 2004, "author": "Lyakhov, D.?", "title": "Universal Primer TMA (uTMA), rationale"}, "model": "feasibility.FeasibilityDocuments", "pk": 53}, {"fields": {"keywords": "TMA, universal, uTMA, S-oligo", "document": "feasibility/uTMA_Step-by-Step_outline_Lyakhov_Apr2004.pdf", "year": 2004, "author": "Lyakhov, D.", "title": "Universal TMA, Step-by-Step"}, "model": "feasibility.FeasibilityDocuments", "pk": 54}, {"fields": {"keywords": "RNA Z, selfish, self-replicating, reverse transcriptase, RNA polymerase; not a Gen-Probe publication, but closely related to TMA side-products", "document": "feasibility/PNAS_1994_91_6093_6097_self-replicating_RNA.pdf", "year": 1994, "author": "Breaker, R.R. & Joyce, G.F.*", "title": "Emergence of a replicating species from an in vitro RNA evolution reaction"}, "model": "feasibility.FeasibilityDocuments", "pk": 55}, {"fields": {"keywords": "TMA, RNA, SRI, PIP, self-replicating, side product, inhibitor", "document": "feasibility/Self_Replicating_Nucleic_Acids_summary_sheet_Brentano_1992.pdf", "year": 1992, "author": "Brentano, S.", "title": "Self Replicating Nucleic Acids [in TMA]"}, "model": "feasibility.FeasibilityDocuments", "pk": 56}, {"fields": {"keywords": "TMA, RNA, SRI, PIP, self-replicating, side product, inhibitor, contamination", "document": "feasibility/TMA_Contamination_Control_Procedures_Brentano_27Oct1997.pdf", "year": 1997, "author": "Brentanto, S.", "title": "Contamination control procedures for R&D at GCD"}, "model": "feasibility.FeasibilityDocuments", "pk": 57}, {"fields": {"keywords": "TMA, RNA, SRI, PIP, self-replicating, side product, inhibitor", "document": "feasibility/TMA_Inhibitor_summary_Wood_and_Brentano_30Nov1999.pdf", "year": 1999, "author": "Wood, L. & Brentano, S.", "title": "Inhibitor Reduction Methods, Characterization of Inhibitor Production & Amplicon Output"}, "model": "feasibility.FeasibilityDocuments", "pk": 58}, {"fields": {"keywords": "TMA, RNA, SRI, PIP, self-replicating, side product, inhibitor", "document": "feasibility/TMA_Inhibitors_Brentano_et_al_Jul1992.pdf", "year": 1992, "author": "Brentano, S., Billyard, B., Dattagupta, N., Kamisango, K., McDonough, S., Ryder, T. & Yang Y.", "title": "on Inhibitory Substances Contributing to Variability in TMA"}, "model": "feasibility.FeasibilityDocuments", "pk": 59}, {"fields": {"keywords": "cell counting, gDNA, Alu repetitive element, HPA, acridinium ester, chemiluminescence", "document": "feasibility/Alu_Cell_Enumeration_Assay_Feasibility_Report_Hanna_Brentano_07Mar2002.pdf", "year": 2002, "author": "Hanna, B. & Brentano, S.", "title": "Alu Cell Enumeration Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 60}, {"fields": {"keywords": "Target Capture, TMA, acridinium ester, chemiluminescence, DKA, Mycobacterium", "document": "feasibility/APTIMA_TB_and_MAC_feasibility_report_Jonas_and_Zaslavsky_Nov2005.pdf", "year": 2005, "author": "Jonas, V. & Zaslavsky, P.", "title": "APTIMA TB and APTIMA MAC"}, "model": "feasibility.FeasibilityDocuments", "pk": 61}, {"fields": {"keywords": "target capture, TMA, acrcidinium ester, chemiluminescence, Coccidioides immitis", "document": "feasibility/Coccidioides_immitis_Amplified_Assay_feasibility_report_McAllister_et_al_06Jun2002.pdf", "year": 2002, "author": "McAllister, D., Clark Dickey, K., Sitay, A., Brentano, S. & Weisburg, W.", "title": "Coccidioides immitis Amplified Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 62}, {"fields": {"keywords": "acridinium ester, chemiluminescence, Probe Matrix, Bacillus anthracis", "document": "feasibility/Culture_Identification_Test_for_Bacillus_anthracis_Bungo_et_al_27Jan2003.pdf", "year": 2003, "author": "Bungo, J., Clark Dickey, K., Gordon, P., Hogan, J., Kaplan, S., Marlowe, B., Norman, S., Sitay, A. & Weisburg, W.", "title": "Culture Identification Test for Bacillus anthracis"}, "model": "feasibility.FeasibilityDocuments", "pk": 63}, {"fields": {"keywords": "target capture, TMA, reverse, degenerate base, universal base, real time, molecular torch, fluorescence, HIV-1 subtype", "document": "feasibility/Degenerate_Universal_Bases_qHIV_Load_summary_report_Blazie_et_al_10Mar2009.pdf", "year": 2009, "author": "Blazie, S., Phelps, S. & Nelson, N.", "title": "Quantification of HIV Viral Load across Multiple Subtypes: Use of Degenerate and Universal Bases in the T7 Provider"}, "model": "feasibility.FeasibilityDocuments", "pk": 64}, {"fields": {"keywords": "TMA, HPA, acridinium ester, chemiluminescence, cancer, prostate, ERG", "document": "feasibility/ERG1_Prostate_Cancer_Marker_Evaluation_report_Lyakhov_2005.pdf", "year": 2005, "author": "Lyakhov, D.", "title": "Cancer Markers Evaluation.  New Prostate Cancer Markers.  ERG1."}, "model": "feasibility.FeasibilityDocuments", "pk": 65}, {"fields": {"keywords": "Target Capture, TMA, acridinium ester, chemiluminescence, ASR, Chlamydia, gonorrhoeae, Mycobacterium, viral pathogens", "document": "feasibility/GeneralPurposeReagents_and_AnalyteSpecificReagents_feasibility_report_Bungo_et_al_14Jun2001.pdf", "year": 2001, "author": "Bungo, J., Cunningham, M., Clark Dickey, K., Sitay. A., Stull, P. & Weisburg, W.", "title": "General Purpose Reagents (GPR) and Analyte Specific Reagents (ASR)"}, "model": "feasibility.FeasibilityDocuments", "pk": 66}, {"fields": {"keywords": "TMA, reverse, multiplex, molecular beacon, fluorescence, melt analysis", "document": "feasibility/HCV_Genotyping_using_RTMA_and_Tm_Analysis_project_report_Hussein_24Nov2009.pdf", "year": 2009, "author": "Hussein, R.", "title": "HCV Genotyping using RTMA and Tm Analysis"}, "model": "feasibility.FeasibilityDocuments", "pk": 67}, {"fields": {"keywords": "TMA, HPA, acridinium ester, chemiluminescence, Hepatitis A Virus", "document": "feasibility/Hepatitis_A_Virus_Assay_Feasibility_Report_Carlson_Brentano_06Dec2001.pdf", "year": 2001, "author": "Carlson, J. & Brentano, S.", "title": "Hepatitis A Virus Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 68}, {"fields": {"keywords": "HLA-A, Luminex, beads, fluorescence", "document": "feasibility/HLA-A Probe_Improvements_summary_report_Peng_and_Nelson_31Oct2010.pdf", "year": 2010, "author": "Peng, D. & Nelson, N.", "title": "HLA-A DNA Assay Probe Improvement"}, "model": "feasibility.FeasibilityDocuments", "pk": 69}, {"fields": {"keywords": "HLA-B, Luminex, beads, fluorescence", "document": "feasibility/HLA-B Probe_Improvements_summary_report_Chelliserrykattil_et_al_31Oct2010.pdf", "year": 2010, "author": "Chelliserrykattil, J., Blazie, S. & Nelson, N.", "title": "HLA-B Probe Improvements"}, "model": "feasibility.FeasibilityDocuments", "pk": 70}, {"fields": {"keywords": "acridinium ester, chemiluminescence, blood, sepsis, bacteria, fungi", "document": "feasibility/HPA_Probe_Matrix_System_feasibility_report_Hogan_18Dec2000.pdf", "year": 2000, "author": "Hogan, J.", "title": "HPA Probe Matrix System"}, "model": "feasibility.FeasibilityDocuments", "pk": 71}, {"fields": {"keywords": "TMA, reverse, multiplex, molecular beacon, fluorescence, melt analysis", "document": "feasibility/HSV_Genotyping_using_RTMA_and_Tm_Analysis_project_report_Hussein_03Dec2009.pdf", "year": 2009, "author": "Hussein, R.", "title": "HSV Genotyping using RTMA and Tm Analysis"}, "model": "feasibility.FeasibilityDocuments", "pk": 72}, {"fields": {"keywords": "Target Capture, TMA, real time, molecular torch, fluorescence, Legionella", "document": "feasibility/Legionela_pneumophila_Assay_development_report_Pollner_Jan2008.pdf", "year": 2008, "author": "Pollner, R.", "title": "Different Versions of the Legionella pneumophila Assay and Assay Performance Aspects"}, "model": "feasibility.FeasibilityDocuments", "pk": 73}, {"fields": {"keywords": "target capture, TMA, real time, fluorescence, miRNA", "document": "feasibility/Micro_RNA_technology_asseement_report_Siva_and_Reynolds_19Jun2008.pdf", "year": 2008, "author": "Siva, A. & Reynolds, M.", "title": "MicroRNA"}, "model": "feasibility.FeasibilityDocuments", "pk": 74}, {"fields": {"keywords": "TMA, reverse, multiplex, molecular beacon, fluorescence, melt analysis", "document": "feasibility/Mycobacterial_Genotyping_by_Melt_Analysis_project_report_Yamagata_29Oct2009.pdf", "year": 2009, "author": "Yamagata, S.", "title": "Mycobacterial Genotyping by Melt Analysis"}, "model": "feasibility.FeasibilityDocuments", "pk": 75}, {"fields": {"keywords": "TMA, real time, multiplex, molecular torch, fluorescence, Mycoplasma", "document": "feasibility/Mycoplasma_Assay_feasibility_report_Livezey_et_al_18Jun2007.pdf", "year": 2007, "author": "Livezey, K., Jiang, A. & Li, W.", "title": "Mycoplasma Feasibility"}, "model": "feasibility.FeasibilityDocuments", "pk": 76}, {"fields": {"keywords": "TMA, acridinium ester, chemiluminescence, Mycoplasma", "document": "feasibility/Mycoplasma_pneumoniae_Assay_feasibility_report_Cunningham_et_al_31Jul2000.pdf", "year": 2000, "author": "Cunningham, M., Clark Dickey, K., Stull, P. & Weisburg, W.", "title": "Mycoplasma pneumoniae Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 77}, {"fields": {"keywords": "TMA, acridinium ester, HPA, chemiluminescence, Parvovirus B19", "document": "feasibility/Parvovirus_B19_Assay_Feasibility_Report_Batranina_Brentano_20Jun2001.pdf", "year": 2001, "author": "Batranina (Kaminsky), M. & Brentano, S.", "title": "Parvovirus B19 Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 78}, {"fields": {"keywords": "TMA, acridinium ester, cheminescence, immuno, magnetic bead, PCA3, PSA, prostate cell", "document": "feasibility/Prostate_Cell_Capture_Technology_report_Jost_and_Reynolds_04Jan2008.pdf", "year": 2008, "author": "Jost, M. & Reynolds, M.", "title": "Cell Capture Technology: Detection of Circulating Prostate Tumor Cells in Blood"}, "model": "feasibility.FeasibilityDocuments", "pk": 79}, {"fields": {"keywords": "target capture, TMA, acridinium ester, chemiluminescence, AMACR", "document": "feasibility/qAMACR_ feasibililty_report_Carlson_2003.pdf", "year": 2003, "author": "Carlson, J.", "title": "AMACR Quantitative AE Assay Design"}, "model": "feasibility.FeasibilityDocuments", "pk": 80}, {"fields": {"keywords": "Target Capture, TMA, acridinium ester, chemiluminescence, HCV", "document": "feasibility/qHCV_ feasibililty_report_Carlson_and_Crose_2003.pdf", "year": 2003, "author": "Carlson, J. & Crose, J.", "title": "QHCV Feasibility"}, "model": "feasibility.FeasibilityDocuments", "pk": 81}, {"fields": {"keywords": "Target Capture, TMA, acridinium ester, chemiluminescence, HIV", "document": "feasibility/qHIV_ feasibililty_report_Crose_and_Carlson_2003.pdf", "year": 2003, "author": "Crose, J. & Carlson, J.", "title": "QHIV Feasibility"}, "model": "feasibility.FeasibilityDocuments", "pk": 82}, {"fields": {"keywords": "TMA, real time, molecular beacon, fluorescence, HIV-1, quantitative", "document": "feasibility/Real_Time_HIV1_Quant_Assay_feasibility_report_Pollner_02Jun2003.pdf", "year": 2003, "author": "Pollner, R.", "title": "Real-Time Monitoring HIV-1 Quantitative Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 83}, {"fields": {"keywords": "TMA, real time, multiplex, molecular beacon, design, fluorescence, Chlamydia, Neisseria", "document": "feasibility/Real-time_Ctr_Cpn_Ctr_Ngo_Multiplex_by_MBs_report_Nelson_07Oct2003.pdf", "year": 2003, "author": "Nelson, N.", "title": "Specific Detection of Chlamydia trachomatis and Chlamydia pneumonia using Molecular Beacons. Multiplex detection of Chlamydia trachomatis and Neisseria gonorrhoeae using Molecular Beacons. Realtime TMA in a 96-well microtiter plate format."}, "model": "feasibility.FeasibilityDocuments", "pk": 84}, {"fields": {"keywords": "target capture, TMA, reverse, real time, HIV-1, subtype, viral load", "document": "feasibility/Realtime_TMA_HIV_Viral_Load_feasibility_report_Gao_30Nov2009.pdf", "year": 2009, "author": "", "title": "Feasibility study of realtime TMA HIV viral load assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 85}, {"fields": {"keywords": "TMA, real time, fluorescence, multiplex, T2:ERGa/PSA/IC", "document": "feasibility/T2ERG_PSA_IC_Triplex_Real_Time_Assay_project_presentation_Walker_07Dec2009.pdf", "year": 2009, "author": "Walker, S.", "title": "T2:ERGa/PSA/IC Triplex Real Time Assay"}, "model": "feasibility.FeasibilityDocuments", "pk": 86}, {"fields": {"keywords": "TMA, real time, quantitative, fluorescence, multiplex, PSA, PCA3, T2ERGA", "document": "feasibility/T2ERGA_sspaTMA_Triplex_report_Gordon_23Aug2010.pdf", "year": 2010, "author": "Gordon, P.", "title": "Sample Split Pre Amp TMA T2ERGA Triplex"}, "model": "feasibility.FeasibilityDocuments", "pk": 87}, {"fields": {"keywords": "TMA, acridinium ester, chemiluminescence, Trichomonas", "document": "feasibility/Trichomonas_vaginalis_Assays_feasibility_report_Bungo_et_al_17Sep2002.pdf", "year": 2002, "author": "Bungo, J., Clark Dickey, K., Gordon, P., Sitay, A. & Weisburg, W.", "title": "Trichomonas vaginalis Assays"}, "model": "feasibility.FeasibilityDocuments", "pk": 88}, {"fields": {"keywords": "CUDA, pellet, reagent, Legionella", "document": "feasibility/Legionella_CUDA_Pellet_project_report_Yamagata_04Feb2008.pdf", "year": 2008, "author": "Yamagata, S.", "title": "Legionella CUDA Pellet Development Report"}, "model": "feasibility.FeasibilityDocuments", "pk": 89}, {"fields": {"keywords": "pellet, enzyme reagent, amplification reagent ", "document": "feasibility/Pelletization_technical_summary_Burns_and_Wood_21Jun1999.pdf", "year": 1999, "author": "Burns, J. & Wood, L.", "title": "Pelletization Technical Summary"}, "model": "feasibility.FeasibilityDocuments", "pk": 90}, {"fields": {"keywords": "AE probe, amplicon, hybridization, selective hydrolysis, chemiluminescence", "document": "feasibility/a_hpa_in_action_video_clip.mov", "year": null, "author": "", "title": "HPA video"}, "model": "feasibility.FeasibilityDocuments", "pk": 91}, {"fields": {"keywords": "molecular beacon, acridinium ester, chemiluminescence", "document": "feasibility/AE_labeled_MBs_feasibility_report_Lam_Becker_27Feb2003.pdf", "year": 2003, "author": "Lam, W.C. & Becker, M.", "title": "AE-Labeled Molecular Beacons"}, "model": "feasibility.FeasibilityDocuments", "pk": 92}, {"fields": {"keywords": "chemiluminescence", "document": "feasibility/Berthold_Sirius_Luminometer_evaluation_report_Eng_09Jun2000.pdf", "year": 2000, "author": "Eng, C.", "title": "A Look at the Berthold Sirius Luminometer"}, "model": "feasibility.FeasibilityDocuments", "pk": 93}, {"fields": {"keywords": "microarray, oligonucleotide, 96 well plate, surface, plastic, glass, covalent bonding", "document": "feasibility/Covalent_Coupling_to_Surfaces_Browne_02Mar2001.pdf", "year": 2001, "author": "Browne, K.A.", "title": "Highlights on Covalent Coupling to Surfaces"}, "model": "feasibility.FeasibilityDocuments", "pk": 94}, {"fields": {"keywords": "target capture, TMA, real time, molecular torch, fluorescence, CUDA, pouch", "document": "feasibility/CUDA_Assay_Integration_summary_report_Peng_29Jan2008.pdf", "year": 2008, "author": "Peng, H.", "title": "Documentation for the CUDA IT#3 Assay Integration"}, "model": "feasibility.FeasibilityDocuments", "pk": 95}, {"fields": {"keywords": "TMA, APTIMA, MilliPROBE, Pseudomonas aeruginosa, HPLC, dNTP, NTP", "document": "feasibility/dNTP_NTP_variability_in_Amp_reagents_Jonas_and_Hogan_16Sep2008.pdf", "year": 2008, "author": "Jonas, V. (Hogan, J., Routley, J., Prihandoko, R., Buttigieg, N., Thomas-Jones, E., Kaplan, S., Garcia,J., Russell, J., Alazard, D. & Decottigenes, S.)", "title": "dNTP/NTP Peak Area Determination and Real-Time TMA Performance Testing of APTIMA Formulation- and the MilliPROBE Pseudomonas aeruginosa Amplification Reagent"}, "model": "feasibility.FeasibilityDocuments", "pk": 96}, {"fields": {"keywords": "EDAC, magnetic particles, MP, coupling", "document": "feasibility/EDAC_reaction_mechanisms_kab_111804.pdf", "year": 2004, "author": "Browne, K.A.", "title": "How Carbodiimide Reactions Impact Coupling of Oligonucleotides to Surfaces"}, "model": "feasibility.FeasibilityDocuments", "pk": 97}, {"fields": {"keywords": "AKTA Oligopilot 100, DNA synthesizer", "document": "feasibility/Eval_Amersham_AKTA_Oligopilot_Synthesizer_Vu_and_Iyer_18Aug2003.pdf", "year": 2003, "author": "Vu, H. & Iyer, L.", "title": "Evaluation of Amersham Biosciences Large Scale Oligonucleotide Synthesizer The AKTA Oligopilot 100"}, "model": "feasibility.FeasibilityDocuments", "pk": 98}, {"fields": {"keywords": "acridinium ester, chemiluminescence", "document": "feasibility/HPA mechanism.pdf", "year": null, "author": "", "title": "HPA scheme"}, "model": "feasibility.FeasibilityDocuments", "pk": 99}, {"fields": {"keywords": "AE, HPA, chemiluminescence", "document": "feasibility/modified_AE_structures.pdf", "year": null, "author": "various", "title": "Modified AE Structures and Light-off Characteristics"}, "model": "feasibility.FeasibilityDocuments", "pk": 100}, {"fields": {"keywords": "oligonucleotide purity, n - 1, HPLC, mass spectrometry", "document": "feasibility/Oligo_Purity_Browne_10Nov2005.pdf", "year": 2005, "author": "Browne, K.A.", "title": "Oligonucleotide Purity Analysis"}, "model": "feasibility.FeasibilityDocuments", "pk": 101}, {"fields": {"keywords": "TMA, real time, probe design, fluorescence", "document": "feasibility/PrimerProbes_summary_report_Phelps_et_al_05Oct2009.pdf", "year": 2009, "author": "Phelps, S., Tseng, E., Kaminsky, M. & Nelson, N.", "title": "Primer-Probes Project"}, "model": "feasibility.FeasibilityDocuments", "pk": 102}, {"fields": {"keywords": "TMA, acridinium ester, chemiluminescence, qualification, TIGRIS", "document": "feasibility/qHIV_TIGRIS_Qualification_Sawyer_Nov2003.pdf", "year": 2003, "author": "Sawyer, G.", "title": "qc-HIV-1 Assay on TIGRIS Qualification"}, "model": "feasibility.FeasibilityDocuments", "pk": 103}, {"fields": {"keywords": "TMA, quantitative, acridinium ester, chemiluminescence, residual wash buffer, TIGRIS", "document": "feasibility/qHPA_Residual_Wash_Study_Sawyer_Dec2003.pdf", "year": 2003, "author": "Sawyer, G.", "title": "Residual Wash Buffer Testing; qHIV and qHC Manual Assays"}, "model": "feasibility.FeasibilityDocuments", "pk": 104}, {"fields": {"keywords": "programmable incubator", "document": "feasibility/Shaker_Baker_Instrument_feasibility_report_Dickey_et_al_24Mar2003.pdf", "year": 2003, "author": "Dickey, K. (Li, F., Kennedy, M., Shaw, J. & Sitay, A.)", "title": "Shaker-Baker Instrument"}, "model": "feasibility.FeasibilityDocuments", "pk": 105}]
